JP2018527014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527014A5 JP2018527014A5 JP2018515108A JP2018515108A JP2018527014A5 JP 2018527014 A5 JP2018527014 A5 JP 2018527014A5 JP 2018515108 A JP2018515108 A JP 2018515108A JP 2018515108 A JP2018515108 A JP 2018515108A JP 2018527014 A5 JP2018527014 A5 JP 2018527014A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- cell
- hiv
- nucleic acid
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222132P | 2015-09-22 | 2015-09-22 | |
| US62/222,132 | 2015-09-22 | ||
| US201562253790P | 2015-11-11 | 2015-11-11 | |
| US62/253,790 | 2015-11-11 | ||
| PCT/US2016/053097 WO2017053556A1 (en) | 2015-09-22 | 2016-09-22 | Method of redirecting t cells to treat hiv infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018527014A JP2018527014A (ja) | 2018-09-20 |
| JP2018527014A5 true JP2018527014A5 (enExample) | 2019-10-31 |
| JP6991131B2 JP6991131B2 (ja) | 2022-02-03 |
Family
ID=58387210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515108A Active JP6991131B2 (ja) | 2015-09-22 | 2016-09-22 | Ｈｉｖ感染症を処置するためにｔ細胞を再度方向付ける方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10738099B2 (enExample) |
| EP (1) | EP3353197A4 (enExample) |
| JP (1) | JP6991131B2 (enExample) |
| KR (1) | KR20180050413A (enExample) |
| CN (1) | CN108779161A (enExample) |
| AU (1) | AU2016326500A1 (enExample) |
| BR (1) | BR112018005741A2 (enExample) |
| CA (1) | CA2999496A1 (enExample) |
| CL (1) | CL2018000750A1 (enExample) |
| EA (1) | EA201890782A1 (enExample) |
| IL (1) | IL258191A (enExample) |
| MA (1) | MA42951A (enExample) |
| MX (1) | MX2018003463A (enExample) |
| PH (1) | PH12018500609A1 (enExample) |
| WO (1) | WO2017053556A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10434153B1 (en) | 2015-05-20 | 2019-10-08 | Kim Leslie O'Neill | Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumors |
| US10738099B2 (en) * | 2015-09-22 | 2020-08-11 | The Trustees Of The University Of Pennsylvania | Method of redirecting T cells to treat HIV infection |
| KR102687212B1 (ko) | 2015-10-25 | 2024-07-19 | 사노피 | Hiv 감염의 예방 또는 치료를 위한 3특이성 및/또는 3가 결합 단백질 |
| JP7153332B2 (ja) | 2016-02-08 | 2022-10-14 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | Ｈｉｖワクチン接種および免疫療法 |
| TN2020000058A1 (en) | 2016-04-13 | 2022-01-06 | Sanofi Sa | Trispecific and/or trivalent binding proteins |
| EP3443006B1 (en) | 2016-04-13 | 2023-08-02 | Sanofi | Trispecific and/or trivalent binding proteins |
| EP3481418A4 (en) | 2016-07-08 | 2020-03-11 | American Gene Technologies International Inc. | PRE-IMMUNIZATION AND IMMUNOTHERAPY OF HIV |
| US20200061117A1 (en) * | 2017-05-08 | 2020-02-27 | The Regents Of The University Of California | Protective Chimeric Antigen Receptor Stem Cell Gene Therapy for Viral Infection |
| WO2018212770A1 (en) * | 2017-05-17 | 2018-11-22 | Thunder Biotech Inc. | Transgenic macrophages, chimeric antigen receptors, and associated methods |
| US10415017B2 (en) | 2017-05-17 | 2019-09-17 | Thunder Biotech, Inc. | Transgenic macrophages, chimeric antigen receptors, and associated methods |
| WO2019084018A1 (en) * | 2017-10-23 | 2019-05-02 | City Of Hope | CAR FOR THE TREATMENT OF HIV INFECTION |
| CN108059675B (zh) * | 2017-12-12 | 2021-09-10 | 武汉波睿达生物科技有限公司 | 重组pg9-car分子的构建及其在清除hiv-1感染细胞中的应用 |
| KR20210031898A (ko) * | 2018-07-13 | 2021-03-23 | 난징 레전드 바이오테크 씨오., 엘티디. | 전염병을 치료하기 위한 공동수용체 시스템 |
| MX2021009020A (es) * | 2019-01-28 | 2021-09-28 | Xyphos Biosciences Inc | Ligandos nkg2d no naturales modificados que entregan selectivamente moleculas heterologas unidas a receptores nkg2d no naturales en celulas car. |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
| CN110358793A (zh) * | 2019-05-30 | 2019-10-22 | 南京艾德免疫治疗研究院有限公司 | 一种用于car-t制备的慢病毒载体制备方法 |
| JP2022535138A (ja) * | 2019-06-07 | 2022-08-04 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｃｄ２８および４－１ｂｂに個々に連結したデュアルｃａｒを発現するｔ細胞 |
| CN110343175B (zh) * | 2019-06-26 | 2021-02-26 | 深圳市再生之城生物医药技术有限公司 | 抑制HIV-1病毒感染的scFv序列及其应用 |
| WO2021178571A1 (en) * | 2020-03-03 | 2021-09-10 | American Gene Technologies International Inc. | On demand expression of exogenous factors in lymphocytes to treat hiv |
| AU2022425312A1 (en) * | 2021-12-31 | 2024-07-18 | Beijing Solobio Genetechnology Co., Ltd. | Chimeric antigen receptor t cells targeting hiv-infected cells |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5851828A (en) * | 1991-03-07 | 1998-12-22 | The General Hospital Corporation | Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| US7049136B2 (en) | 1991-03-07 | 2006-05-23 | The General Hospital Corporation | Redirection of cellular immunity by receptor chimeras |
| WO1993006216A1 (en) * | 1991-09-26 | 1993-04-01 | Oklahoma Medical Research Foundation | Fusion proteins targeted to lysosomes, for the treatment of aids |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| CA2195653C (en) * | 1994-08-02 | 2010-04-27 | Brian Seed | Cells bearing cd4 decoy receptors and related molecules and methods |
| EP1235842A4 (en) | 1999-10-15 | 2003-04-23 | Univ Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| AU2001275474A1 (en) | 2000-06-12 | 2001-12-24 | Akkadix Corporation | Materials and methods for the control of nematodes |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| US9708384B2 (en) * | 2011-09-22 | 2017-07-18 | The Trustees Of The University Of Pennsylvania | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens |
| EP3594245A1 (en) | 2012-02-13 | 2020-01-15 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| CN112375846A (zh) | 2012-07-13 | 2021-02-19 | 宾夕法尼亚大学董事会 | 评估用于施用的转导t细胞的适用性的方法 |
| US9573988B2 (en) | 2013-02-20 | 2017-02-21 | Novartis Ag | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells |
| TWI654206B (zh) * | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
| CA2954168C (en) | 2013-08-02 | 2023-09-19 | The Regents Of The University Of California | Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors |
| US10144770B2 (en) | 2013-10-17 | 2018-12-04 | National University Of Singapore | Chimeric receptors and uses thereof in immune therapy |
| AU2014352638B2 (en) * | 2013-11-25 | 2018-08-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric antigen receptors to control HIV infection |
| US10934346B2 (en) | 2014-02-14 | 2021-03-02 | Bellicum Pharmaceuticals, Inc. | Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 |
| DK3166968T3 (da) * | 2014-05-02 | 2021-12-06 | Univ Pennsylvania | Sammensætninger og fremgangsmåder til kimæriske autoantistofreceptor-T-celler |
| US10738099B2 (en) * | 2015-09-22 | 2020-08-11 | The Trustees Of The University Of Pennsylvania | Method of redirecting T cells to treat HIV infection |
-
2016
- 2016-09-22 US US15/761,563 patent/US10738099B2/en active Active
- 2016-09-22 KR KR1020187011293A patent/KR20180050413A/ko not_active Withdrawn
- 2016-09-22 JP JP2018515108A patent/JP6991131B2/ja active Active
- 2016-09-22 CA CA2999496A patent/CA2999496A1/en active Pending
- 2016-09-22 BR BR112018005741A patent/BR112018005741A2/pt not_active Application Discontinuation
- 2016-09-22 WO PCT/US2016/053097 patent/WO2017053556A1/en not_active Ceased
- 2016-09-22 EA EA201890782A patent/EA201890782A1/ru unknown
- 2016-09-22 EP EP16849585.1A patent/EP3353197A4/en active Pending
- 2016-09-22 MX MX2018003463A patent/MX2018003463A/es unknown
- 2016-09-22 CN CN201680066602.4A patent/CN108779161A/zh active Pending
- 2016-09-22 MA MA042951A patent/MA42951A/fr unknown
- 2016-09-22 AU AU2016326500A patent/AU2016326500A1/en not_active Abandoned
-
2018
- 2018-03-18 IL IL258191A patent/IL258191A/en unknown
- 2018-03-21 PH PH12018500609A patent/PH12018500609A1/en unknown
- 2018-03-21 CL CL2018000750A patent/CL2018000750A1/es unknown
-
2020
- 2020-08-07 US US16/988,415 patent/US12122820B2/en active Active
-
2024
- 2024-09-13 US US18/885,127 patent/US20250084147A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12435118B2 (en) | Chimeric antigen receptor and natural killer cells expressing same | |
| JP2021000103A5 (enExample) | ||
| JP2017524367A5 (enExample) | ||
| JP2024507996A5 (enExample) | ||
| US20170281682A1 (en) | Chimeric receptors and uses thereof in immune therapy | |
| JP2019523301A5 (enExample) | ||
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2022530773A5 (enExample) | ||
| US20220289842A1 (en) | Chimeric inhibitory receptor | |
| JP2024527557A5 (enExample) | ||
| WO2019087151A1 (en) | Cd38-directed chimeric antigen receptor constructs | |
| RU2019128921A (ru) | Антитело к il-13ra2 и его применение | |
| WO2024086190A9 (en) | Novel cd19 binders, car-t constructs comprising the same, and methods of using the same | |
| CN115279792A (zh) | 对bcma特异的抗体及嵌合抗原受体 | |
| JP2024534847A5 (enExample) | ||
| JP2020500903A5 (enExample) | ||
| JP2022538425A5 (enExample) | ||
| IL266950B2 (en) | ?? ? cells that express chimeric antigen receptor for use in immunotherapy | |
| KR20210111244A (ko) | 태반-유래 동종이계 car-t 세포 및 이의 용도 | |
| US20240131068A1 (en) | Car-t constructs comprising a novel cd19 binder combined with il18 and methods of using the same | |
| US20240384293A1 (en) | Viral vector production system | |
| JP2025501273A (ja) | Ｈｉｖ感染細胞を標的とするキメラ抗原受容体ｔ細胞 | |
| IL303060A (en) | Chimeric receptors and methods of their use | |
| JP2023518930A5 (enExample) |